The Absence of Association Between NQO1 rs1800566 Polymorphism and Promoter Methylation With the Risk of Preeclampsia
Oxidative Medicine and Cellular Longevity · 2025
DOI: 10.1155/omcl/1490896 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oxidative Medicine and Cellular Longevity, 2025. Verfasst von Maryam Pourmahmood und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran. Hauptthemen laut MEDLINE: Pre-Eclampsia, NAD(P)H Dehydrogenase (Quinone), Promoter Regions, Genetic, DNA Methylation. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kermanshah University of Medical Sciences.
Abstract (Originalsprache)
Background
Oxidative stress plays a crucial role in the pathogenesis of preeclampsia. Given that the NADPH quinone oxidoreductase 1 (NQO1) is an important enzyme in the antioxidant system, this study aimed to investigate the relationship between the NQO1 rs1800566 polymorphism, NQO1 promoter methylation, and oxidative stress with the risk of preeclampsia.
Methods
This case‐control study analyzed 170 women, including preeclampsia patients and healthy pregnant women. To investigate the NQO1 rs1800566 variants, the polymerase chain reaction‐restriction fragment length polymorphism (PCR‐RFLP) method was used. Promoter methylation analysis in 96 of these samples was conducted using quantitative methylation‐specific PCR (qMSP) method. Glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity, along with zinc (Zn), copper (Cu), selenium (Se), malondialdehyde (MDA), and total antioxidant capacity (TAC) levels were measured using chemical methods.
Results
We found reduced levels of TAC, Zn, and Se, and also the SOD activity in patients than controls. However, the MDA and Cu levels, and the GPx activity increased in preeclamptic patients. No association was identified between the NQO1 rs1800566 variants or NQO1 promoter methylation with the risk of preeclampsia.
Conclusion
It seems the NQO1 rs1800566 and the promoter methylation of NQO1 gene are not involved in the risk of preeclampsia. However, our findings indicate the presence of oxidative stress in preeclamptic patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
ORCID-Profile: Maryam Pourmahmood, Somayeh Rahimi, Nayebali Rezvani, Ebrahim Shakiba, Zohreh Rahimi
Förderung
- Kermanshah University of Medical Sciences
Zitieren
APA
Pourmahmood, M., Rahimi, S., Rezvani, N., Shakiba, E., & Rahimi, Z. (2025). The Absence of Association Between NQO1 rs1800566 Polymorphism and Promoter Methylation With the Risk of Preeclampsia. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/omcl/1490896
Vancouver
Pourmahmood M, Rahimi S, Rezvani N, Shakiba E, Rahimi Z. The Absence of Association Between NQO1 rs1800566 Polymorphism and Promoter Methylation With the Risk of Preeclampsia. Oxidative Medicine and Cellular Longevity. 2025. doi:10.1155/omcl/1490896
BibTeX
@article{Pourmahmood2025,
author = {Pourmahmood, Maryam and Rahimi, Somayeh and Rezvani, Nayebali and Shakiba, Ebrahim and Rahimi, Zohreh},
title = {The Absence of Association Between NQO1 rs1800566 Polymorphism and Promoter Methylation With the Risk of Preeclampsia},
journal = {Oxidative Medicine and Cellular Longevity},
year = {2025},
doi = {10.1155/omcl/1490896}
}
EUVIMED